《Table 3 Screening of diabetes-related complications in patients with diabetes mellitus》

《Table 3 Screening of diabetes-related complications in patients with diabetes mellitus》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Management and control of type 2 diabetes mellitus in Lebanon:Results from the International Diabetes Management Practices Study Wave 6》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录

Dyslipidemia was found to be prevalent among our patients with diabetes mellitus（68.4%），and 94.8%were being treated（Table 5）.Concerning the patients’fasting lipid profile，39.2%of patients had an LDL<100 mg/dL and their mean fasting LDL was125.45±135.12 mg/dL.In contrast，44%of the type 2 diabetic population had triglyceride levels below 150 mg/dL in 2013，with a mean TG level of 178.53±104.12.In addition，86.5%of treated patients were on statin therapy.

图表编号XD0058748700    严禁用于非法目的
绘制时间2019.04.15
作者Hala Ahmadieh、Marie-Therese Sawaya、Sami T Azar
绘制单位Department of Medicine, Beirut Arab University、Medical Affairs Department, Sanofi-aventis Lebanon、Department of Internal Medicine, Division of Endocrinology, American University of Beirut-Medical Center
更多格式高清、无水印（增值服务）

相关图表

  1. 《表3 两组患者并发症发生率的比较[n (%) ]Table 3 Comparison of the incidence of complications in the two groups[n (%) ]》2018.08.20
  2. 《Table 3 Multivariable analysis of risk factors for development of venous thromboembolism in patients with hepatic cirrho》2019.04.27
  3. 《Table 4 Reported diabetes-related complications for patients with type 2 diabetes mellitus》2019.04.15
  4. 《表2 口腔颌面部间隙感染患者严重并发症分布Tab.2 Distribution of severe complications in patients with oral and maxillofacial space infection》2019.02.28
  5. 《Table 3.Comparison of Blood Gas Indices in Septic Shock Patients between Groups (±s)》2019.01.01
  6. 《Table 3.Changes of lymphocyte sabsets in WAS patients》2019.02.20
  7. 《Table 1.Clinical data of the patients in 3 three groups》2019.02.20
  8. 《Table 3 Anatomical locations of regions with significant clinical correlation in iRBD patients》2019.05.01
  9. 《表4 病人术后并发症发生率对比 (n, %) Tab.4 Comparison of the incidence of postoperative complications in patients (n, %)》2019.02.01
  10. 《Table 3.Comparison for the use of muscle relaxant in trauma patients (n, %)》2019.01.01
  11. 《Table 3 The pooled results of prevalence of DR, PDR and NPDR in patients with DM》2019.02.18
  12. 《Table 3 Mean volume measurements of nasolacrimal ducts in patients and controls》2019.01.18
  13. 《表4 不同合并症患者结石成分比较Table 4 Comparison of calculi composition in patients with different complications》2018.08.01
  14. 《表3 2组并发症发生情况比较[n (%) ]Table 3 Comparison of complications in 2 groups[n (%) ]》2018.07.25
  15. 《表2 2组并发症发生情况比较[n (%) ]Table 2 Comparison of complications in 2 groups[n (%) ]》2018.07.15
  16. 《Table 3 The ORL, RPE layer thickness in healthy individuals and diabetic patient groups in terms of any measurement》2018.12.18
  17. 《Table 2Comparison of patients with and without postoperative complications.》2018.10.15
  18. 《表5 两组术后并发症情况Tab 5 Postoperative complications in the two groups of patients》2018.02.20
  19. 《表2 术后各组患者常见并发症发生情况Tab.2 Common complications of patients in various groups after operation》2018.03.28
  20. 《表2 12 934名足月儿组眼疾筛查结果Table 2 Screening results of eye diseases in 3717 term infants》2018.04.20

随机翻阅

《表1 两组新生儿临床护理中的体温波动、血氧饱和度比较（±s)》 《表2 不同年龄段组患儿听力学检查情况比较》 《表2 形成性评价指标权重》 《表2 表层土壤样品重金属含量分析结果(mg/kg)及p H值》 《表5 粤港澳大湾区各地部分优势产业及区位熵值》 《表3 智慧管理模块功能列表》 《表1 两组患者的SAS和SDS评分比较（±s，分）》 《表2 不同等级白茶样品香气成分的相对含量》 《表1 水泥技术指标(山水P.S.A42.5)》 《表2 基于“H-I-S”维度的传统村落类型划分》